What Have We Learned from Cerebrospinal Fluid Studies about Biomarkers for Detecting LRRK2 Parkinson’s Disease Patients and Healthy Subjects with Parkinson’s-Associated LRRK2 Mutations?

Mutations in the leucine-rich repeat kinase 2 (LRRK2) gene are the most common known cause of autosomal dominant Parkinson’s disease (PD) and sporadic PD (sPD). The clinical presentation of LRRK2 PD is similar to sPD, and except for genetic testing, no biochemical or imaging markers can differentiat...

Descripción completa

Detalles Bibliográficos
Autores principales: Loeffler, David A., Aasly, Jan O., LeWitt, Peter A., Coffey, Mary P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: IOS Press 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6700639/
https://www.ncbi.nlm.nih.gov/pubmed/31322581
http://dx.doi.org/10.3233/JPD-191630

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6700639/
https://www.ncbi.nlm.nih.gov/pubmed/31322581
http://dx.doi.org/10.3233/JPD-191630

Ejemplares similares